切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2026, Vol. 15 ›› Issue (02) : 257 -260. doi: 10.3877/cma.j.issn.2095-3232.2026.02.017

综述

ICG荧光影像在肝脏肿瘤解剖性肝切除术中的应用
郑述昊, 李威威, 袁文康, 张超, 张冲()   
  1. 230022 合肥,安徽医科大学第一附属医院普通外科
  • 收稿日期:2025-07-24 出版日期:2026-04-10
  • 通信作者: 张冲
  • 基金资助:
    国家自然科学基金(82303475); 安徽省高等学校科学研究项目(2022AH040161)

Application of ICG fluorescence image in anatomical liver resection of liver tumors

Shuhao Zheng, Weiwei Li, Wenkang Yuan, Chao Zhang, Chong Zhang()   

  1. Department of General Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
  • Received:2025-07-24 Published:2026-04-10
  • Corresponding author: Chong Zhang
引用本文:

郑述昊, 李威威, 袁文康, 张超, 张冲. ICG荧光影像在肝脏肿瘤解剖性肝切除术中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 257-260.

Shuhao Zheng, Weiwei Li, Wenkang Yuan, Chao Zhang, Chong Zhang. Application of ICG fluorescence image in anatomical liver resection of liver tumors[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(02): 257-260.

肝脏肿瘤多采用以肝切除术为主的综合治疗。解剖性肝切除术(ALR)在肝脏肿瘤治疗中优势已经广泛被业内认可,但确定精准的肝脏切除范围对术者而言有一定难度。ICG荧光影像技术应用历史较久且相对安全,可在术中成像识别肝脏肿瘤,能辅助提高解剖性肝切除的精度。然而ICG存在穿透力有限、假阳性率高等缺陷,其临床疗效尚存争议。本文综述ICG荧光腹腔镜技术的发展、应用、在肝脏肿瘤中的成像机制以及该技术的缺陷与不足,为未来ICG荧光影像技术在肝切除术中的应用提供参考。

Liver tumors are primarily treated with comprehensive therapy based on liver resection. The advantages of anatomical liver resection (ALR) in the treatment of liver tumors have been widely recognized in this field. However, it is challenging for the surgeons to precisely determine the scope of liver resection. ICG fluorescence imaging technology has been adopted for a long period of time and it is relatively safe, which can identify liver tumors during intraoperative imaging and enhance the precision of ALR. However, ICG has limited penetration and high false positive rate, and its clinical efficacy remains controversial. In this article, the development, application, imaging mechanism of ICG fluorescence laparoscopy in liver tumors, and its defects and limitations were reviewed, aiming to provide reference for the application of ICG fluorescence imaging technology in LAR in the future.

[1]
Kosuge T, Makuuchi M, Takayama T, et al. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases[J]. Hepatogastroenterology, 1993, 40(4): 328-332.
[2]
Minagawa M, Mise Y, Omichi K, et al. Anatomic resection for hepatocellular carcinoma: prognostic impact assessed from recurrence treatment[J]. Ann Surg Oncol, 2022, 29(2): 913-921.DOI: 10.1245/s10434-021-10380-9.
[3]
李相成, 江王杰. 解剖性肝切除的沿革[J]. 外科理论与实践, 2020, 25(1): 20-24.DOI: 10.16139/j.1007-9610.2020.01.005.
[4]
Brudvik KW, Mise Y, Chung MH, et al. RAS mutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases[J]. Ann Surg Oncol, 2016, 23(8): 2635-2643.DOI: 10.1245/s10434-016-5187-2.
[5]
Yamashita S, Venkatesan AM, Mizuno T, et al. Remnant liver ischemia as a prognostic factor for cancer-specific survival after resection of colorectal liver metastases[J]. JAMA Surg, 2017, 152(10): e172986.DOI: 10.1001/jamasurg.2017.2986.
[6]
Si A, Li J, Yang Z, et al. Impact of anatomical versus non-anatomical liver resection on short-and long-term outcomes for patients with intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2019, 26(6): 1841-1850.DOI: 10.1245/s10434-019-07260-8.
[7]
Takemura N, Ito K, Inagaki F, et al. Added value of indocyanine green fluorescence imaging in liver surgery[J]. Hepatobiliary Pancreat Dis Int, 2022, 21(4): 310-317.DOI: 10.1016/j.hbpd.2021.12.007.
[8]
He P, Huang T, Fang C, et al. Identification of extrahepatic metastasis of hepatocellular carcinoma using indocyanine green fluorescence imaging[J]. Photodiagnosis Photodyn Ther, 2019, 25: 417-420.DOI: 10.1016/j.pdpdt.2019.01.031.
[9]
Souzaki R, Kawakubo N, Matsuura T, et al. Navigation surgery using indocyanine green fluorescent imaging for hepatoblastoma patients[J]. Pediatr Surg Int, 2019, 35(5): 551-557.DOI: 10.1007/s00383-019-04458-5.
[10]
Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy[J]. Surg Gynecol Obstet, 1985, 161(4): 346-350.
[11]
Tanaka T, Takatsuki M, Hidaka M, et al. Is a fluorescence navigation system with indocyanine green effective enough to detect liver malignancies?[J]. J Hepatobiliary Pancreat Sci, 2014, 21(3): 199-204.DOI: 10.1002/jhbp.17.
[12]
Aoki T, Yasuda D, Shimizu Y, et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection[J]. World J Surg, 2008, 32(8): 1763-1767.DOI: 10.1007/s00268-008-9620-y.
[13]
Ishizawa T, Zuker NB, Kokudo N, et al. Positive and negative staining of hepatic segments by use of fluorescent imaging techniques during laparoscopic hepatectomy[J]. Arch Surg, 2012, 147(4): 393-394.DOI: 10.1001/archsurg.2012.59.
[14]
Sakoda M, Ueno S, Iino S, et al. Anatomical laparoscopic hepatectomy for hepatocellular carcinoma using indocyanine green fluorescence imaging[J]. J Laparoendosc Adv Surg Tech A, 2014, 24(12): 878-882.DOI: 10.1089/lap.2014.0243.
[15]
Wang X, Teh CSC, Ishizawa T, et al. Consensus guidelines for the use of fluorescence imaging in hepatobiliary surgery[J]. Ann Surg, 2021, 274(1): 97-106.DOI: 10.1097/SLA.0000000000004718.
[16]
Speich R, Saesseli B, Hoffmann U, et al. Anaphylactoid reactions after indocyanine-green administration[J]. Ann Intern Med, 1988, 109(4): 345-346.DOI: 10.7326/0003-4819-109-4-345_2.
[17]
Takahashi H, Zaidi N, Berber E. An initial report on the intraoperative use of indocyanine green fluorescence imaging in the surgical management of liver tumorss[J]. J Surg Oncol, 2016, 114(5): 625-629.DOI: 10.1002/jso.24363.
[18]
Lau CT, Au DM, Wong KY. Application of indocyanine green in pediatric surgery[J]. Pediatr Surg Int, 2019, 35(10): 1035-1041.DOI: 10.1007/s00383-019-04502-4.
[19]
Treger JS, Priest MF, Iezzi R, et al. Real-time imaging of electrical signals with an infrared FDA-approved dye[J]. Biophys J, 2014, 107(6): L09-L12.DOI: 10.1016/j.bpj.2014.07.054.
[20]
Noma K, Shirakawa Y, Kanaya N, et al. Visualized evaluation of blood flow to the gastric conduit and complications in esophageal reconstruction[J]. J Am Coll Surg, 2018, 226(3): 241-251.DOI: 10.1016/j.jamcollsurg.2017.11.007.
[21]
梁霄, 杨再博. 腹腔镜肝癌切除术的肿瘤学风险及对策[J]. 中国实用外科杂志, 2022, 42(9): 979-982.DOI: 10.19538/j.cjps.issn1005-2208.2022.09.05.
[22]
岳珂珂, 吴大帅, 黄运德, 等. 吲哚菁绿荧光成像技术在巴塞罗那肝癌分期B期肝细胞肝癌行腹腔镜肝切除术中的应用[J]. 肿瘤基础与临床, 2024, 37(4): 417-420.DOI: 10.3969/j.issn.1673-5412.2024.04.012.
[23]
中国医师协会外科医师分会肝脏外科医师委员会. 吲哚菁绿荧光成像技术在肝脏外科应用中国专家共识(2023版)[J]. 中国实用外科杂志, 2023, 43(4): 371-383.DOI: 10.19538/j.cjps.issn1005-2208.2023.04.02.
[24]
武林得, 涂勇浪, 高国华, 等. 吲哚菁绿荧光胆管造影在复杂性腹腔镜胆囊切除术中有效性及安全性的meta分析[J]. 中国当代医药, 2024, 31(11): 14-19, 24.DOI: 10.3969/j.issn.1674-4721.2024.11.005.
[25]
方晶晶, 王金波, 应立平. 吲哚菁绿荧光导航结合术中B超在腹腔镜下肝多发微小病灶切除中的应用[J]. 现代实用医学, 2021, 33(9): 1144-1146, 1261.DOI: 10.3969/j.issn.1671-0800.2021.09.009.
[26]
Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging[J]. Cancer, 2009, 115(11): 2491-2504.DOI: 10.1002/cncr.24291.
[27]
Ishizawa T, Masuda K, Urano Y, et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma[J]. Ann Surg Oncol, 2014, 21(2): 440-448.DOI: 10.1245/s10434-013-3360-4.
[28]
van der Vorst JR, Schaafsma BE, Hutteman M, et al. Near-infrared fluorescence-guided resection of colorectal liver metastases[J]. Cancer, 2013, 119(18): 3411-3418.DOI: 10.1002/cncr.28203.
[29]
Shibasaki Y, Sakaguchi T, Hiraide T, et al. Expression of indocyanine green-related transporters in hepatocellular carcinoma[J]. J Surg Res, 2015, 193(2): 567-576.DOI: 10.1016/j.jss.2014.07.055.
[30]
Harada N, Ishizawa T, Muraoka A, et al. Fluorescence navigation hepatectomy by visualization of localized cholestasis from bile duct tumor infiltration[J]. J Am Coll Surg, 2010, 210(6): e2-6.DOI: 10.1016/j.jamcollsurg.2010.02.052.
[31]
Yokoyama N, Otani T, Hashidate H, et al. Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: preliminary results of a prospective study[J]. Cancer, 2012, 118(11): 2813-2819.DOI: 10.1002/cncr.26594.
[32]
Satou S, Ishizawa T, Masuda K, et al. Indocyanine green fluorescent imaging for detecting extrahepatic metastasis of hepatocellular carcinoma[J]. J Gastroenterol, 2013, 48(10): 1136-1143.DOI: 10.1007/s00535-012-0709-6.
[33]
Kudo H, Ishizawa T, Tani K, et al. Visualization of subcapsular hepatic malignancy by indocyanine-green fluorescence imaging during laparoscopic hepatectomy[J]. Surg Endosc, 2014, 28(8): 2504-2508.DOI: 10.1007/s00464-014-3468-z.
[34]
Liu P, Wei M, Sun D, et al. Study on the application of preoperative three-dimensional CT angiography of perigastric arteries in laparoscopic radical gastrectomy[J]. Sci Rep, 2022, 12(1): 6026.DOI: 10.1038/s41598-022-09584-0.
[35]
Gotoh K, Yamada T, Ishikawa O, et al. A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation[J]. J Surg Oncol, 2009, 100(1): 75-79.DOI: 10.1002/jso.21272.
[36]
Egloff-Juras C, Bezdetnaya L, Dolivet G, et al. NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green[J]. Int J Nanomedicine, 2019, 14: 7823-7838.DOI: 10.2147/IJN.S207486.
[37]
Saito Y, Shimada M, Morine Y, et al. Essential updates 2020/2021: current topics of simulation and navigation in hepatectomy[J]. Ann Gastroenterol Surg, 2021, 6(2): 190-196.DOI: 10.1002/ags3.12542.
[1] 徐一航, 彭丽婷, 林嘉谊, 曹清华, 汪跃锋, 陈丽丽, 廖冰. 结构化病理报告对肝细胞癌手术病理报告质量的影响:一项回顾性研究[J/OL]. 中华普通外科学文献(电子版), 2026, 20(01): 30-34.
[2] 方郁晖, 常钰泉, 何坤. 伴微血管侵犯的肝细胞癌术后辅助介入治疗的研究进展[J/OL]. 中华普通外科学文献(电子版), 2026, 20(01): 53-59.
[3] 崔梦玲, 孙文梅, 赵睿敏, 王家平. 合并微血管侵犯肝癌术后TACE联合治疗的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 160-166.
[4] 牛晓华, 黄长文. 腹腔镜肝切除平面探讨:多技术融合肝切除平面定位策略理论与实践[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 167-171.
[5] 东小鸽, 樊海宁, 侯立朝, 杜凯豪, 刘海刚, 汪占金, 薛伟伟, 石亚超, 魏六木, 王展. 三维可视化技术、ICG荧光示踪和术中实时超声在肝癌个性化精准诊疗中应用[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 181-189.
[6] 邢颖, 王峰. 基于机器学习构建肝切除术后肝衰竭预测列线图模型及其预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 190-196.
[7] 吴杰嵘, 严庆, 胡健垣, 陈焕伟. 复发性肝细胞癌再次手术切除与射频消融临床疗效比较[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 211-218.
[8] 魏海鸽, 游川, 龚财芳, 李晓琴, 邹小红. 互联网+ERAS信息化系统在肝癌患者术后加速康复中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 219-225.
[9] 唐玥, 陈家璐, 覃德龙, 李宗龙, 汤朝晖, 全志伟. 基于AI的多模态影像在肝癌诊治中应用及面临挑战[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 4-9.
[10] 杨宇尘, 陈拥军. 三维可视化技术在肝癌转化治疗辅助决策中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 10-15.
[11] 刘建平, 姚灿开. 肝癌转化治疗策略选择和手术时机[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 16-20.
[12] 尹鹏飞, 吴堃, 王槐志, 蔡磊. 肝癌免疫治疗策略及其在围手术期中应用进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 21-27.
[13] 张龙, 徐伟, 孙善柯, 李文柱, 李俊达, 池涌泉, 宋进华, 王学浩, 成峰, 饶建华. 载药微球经动脉栓塞化疗在巨块型肝癌转化治疗中的疗效及安全性[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 28-35.
[14] 戴宗伯, 张城硕, 郭庭维, 何知远, 赵昊宇, 张宇慈, 张佳林. 基于MRI影像组学机器学习构建肝细胞癌微血管侵犯预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 36-44.
[15] 何泰霖, 王峻峰, 田林云, 王罡, 杨超, 王海峰. 基于CT影像组学构建肝细胞癌微血管侵犯预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 45-52.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?